Overview

A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%

Status:
Completed
Trial end date:
2020-11-24
Target enrollment:
Participant gender:
Summary
This is a post-approval, open-label, randomized, self-controlled prospective clinical study to evaluate the safety and ocular efficacy of Dexycu in controlling postoperative ocular pain and inflammation associated with cataract surgery.
Phase:
Phase 4
Details
Lead Sponsor:
MDbackline, LLC
Research Insight LLC
Treatments:
BB 1101
Dexamethasone
Dexamethasone acetate
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Moxifloxacin
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate